| pubmed-article:19725474 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19725474 | lifeskim:mentions | umls-concept:C1707801 | lld:lifeskim |
| pubmed-article:19725474 | lifeskim:mentions | umls-concept:C0201811 | lld:lifeskim |
| pubmed-article:19725474 | lifeskim:mentions | umls-concept:C0031322 | lld:lifeskim |
| pubmed-article:19725474 | lifeskim:mentions | umls-concept:C0281185 | lld:lifeskim |
| pubmed-article:19725474 | pubmed:issue | 7-8 | lld:pubmed |
| pubmed-article:19725474 | pubmed:dateCreated | 2009-9-3 | lld:pubmed |
| pubmed-article:19725474 | pubmed:abstractText | We conducted a colorectal cancer (CRC) screening program, in which public pharmacies provided the faecal occult blood test (FOBT), addressed to 50-70 years residents of 12th Municipality of Rome. A total of 5003 subjects were invited and 1103 (22.0%) performed the screening test, the adjusted compliance was 24.0%. Among 72 (6.5%) FOBT-positive subjects, 50 (69.5%) had colonoscopies; a CRC was detected in 5 subjects. Screening through the public pharmacies was feasible but the limited number of pharmacies enrolled have influenced compliance. A screening model that offers multiple providers (including private pharmacies) should be tested in order to improve screening compliance. | lld:pubmed |
| pubmed-article:19725474 | pubmed:language | ita | lld:pubmed |
| pubmed-article:19725474 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19725474 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19725474 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19725474 | pubmed:issn | 0034-1193 | lld:pubmed |
| pubmed-article:19725474 | pubmed:author | pubmed-author:BarcaAlessand... | lld:pubmed |
| pubmed-article:19725474 | pubmed:author | pubmed-author:FerraraMarcoM | lld:pubmed |
| pubmed-article:19725474 | pubmed:author | pubmed-author:FedericiAnton... | lld:pubmed |
| pubmed-article:19725474 | pubmed:author | pubmed-author:ValleSabrinaS | lld:pubmed |
| pubmed-article:19725474 | pubmed:author | pubmed-author:BaiocchiDiego... | lld:pubmed |
| pubmed-article:19725474 | pubmed:author | pubmed-author:PippaGiovanna... | lld:pubmed |
| pubmed-article:19725474 | pubmed:author | pubmed-author:ApuzzoMarcell... | lld:pubmed |
| pubmed-article:19725474 | pubmed:author | pubmed-author:BazuroMarco... | lld:pubmed |
| pubmed-article:19725474 | pubmed:author | pubmed-author:TammaroGianfr... | lld:pubmed |
| pubmed-article:19725474 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:19725474 | pubmed:volume | 100 | lld:pubmed |
| pubmed-article:19725474 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19725474 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19725474 | pubmed:pagination | 348-51 | lld:pubmed |
| pubmed-article:19725474 | pubmed:meshHeading | pubmed-meshheading:19725474... | lld:pubmed |
| pubmed-article:19725474 | pubmed:meshHeading | pubmed-meshheading:19725474... | lld:pubmed |
| pubmed-article:19725474 | pubmed:meshHeading | pubmed-meshheading:19725474... | lld:pubmed |
| pubmed-article:19725474 | pubmed:meshHeading | pubmed-meshheading:19725474... | lld:pubmed |
| pubmed-article:19725474 | pubmed:meshHeading | pubmed-meshheading:19725474... | lld:pubmed |
| pubmed-article:19725474 | pubmed:meshHeading | pubmed-meshheading:19725474... | lld:pubmed |
| pubmed-article:19725474 | pubmed:meshHeading | pubmed-meshheading:19725474... | lld:pubmed |
| pubmed-article:19725474 | pubmed:meshHeading | pubmed-meshheading:19725474... | lld:pubmed |
| pubmed-article:19725474 | pubmed:meshHeading | pubmed-meshheading:19725474... | lld:pubmed |
| pubmed-article:19725474 | pubmed:meshHeading | pubmed-meshheading:19725474... | lld:pubmed |
| pubmed-article:19725474 | pubmed:meshHeading | pubmed-meshheading:19725474... | lld:pubmed |
| pubmed-article:19725474 | pubmed:meshHeading | pubmed-meshheading:19725474... | lld:pubmed |
| pubmed-article:19725474 | pubmed:meshHeading | pubmed-meshheading:19725474... | lld:pubmed |
| pubmed-article:19725474 | pubmed:meshHeading | pubmed-meshheading:19725474... | lld:pubmed |
| pubmed-article:19725474 | pubmed:meshHeading | pubmed-meshheading:19725474... | lld:pubmed |
| pubmed-article:19725474 | pubmed:meshHeading | pubmed-meshheading:19725474... | lld:pubmed |
| pubmed-article:19725474 | pubmed:meshHeading | pubmed-meshheading:19725474... | lld:pubmed |
| pubmed-article:19725474 | pubmed:articleTitle | [Feasibility of colorectal cancer screening with fecal occult blood test distributed by public pharmacies]. | lld:pubmed |
| pubmed-article:19725474 | pubmed:affiliation | Unità Operativa Complessa di Gastroenterologia ed Endoscopia Digestiva, Ospedale Sant'Eugenio, Roma. pippag@tiscali.it | lld:pubmed |
| pubmed-article:19725474 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19725474 | pubmed:publicationType | English Abstract | lld:pubmed |
